Tomoyasu Jo

572 total citations
37 papers, 268 citations indexed

About

Tomoyasu Jo is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Tomoyasu Jo has authored 37 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 19 papers in Oncology and 7 papers in Immunology. Recurrent topics in Tomoyasu Jo's work include Hematopoietic Stem Cell Transplantation (14 papers), CAR-T cell therapy research (12 papers) and Immune Cell Function and Interaction (5 papers). Tomoyasu Jo is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), CAR-T cell therapy research (12 papers) and Immune Cell Function and Interaction (5 papers). Tomoyasu Jo collaborates with scholars based in Japan, United States and Sweden. Tomoyasu Jo's co-authors include Yasuyuki Arai, Akifumi Takaori‐Kondo, Tadakazu Kondo, Hiroyuki Matsui, Kouhei Yamashita, Junya Kanda, Toshio Heike, Momoko Nishikori, Hironori Haga and Hiroto Egawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Tomoyasu Jo

31 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomoyasu Jo Japan	9	113	102	51	46	44	37	268
Yasser Khaled United States	8	232 2.1×	126 1.2×	161 3.2×	32 0.7×	83 1.9×	27	385
Mohamed Samra Egypt	10	109 1.0×	84 0.8×	45 0.9×	46 1.0×	67 1.5×	44	296
Elia Girolami Italy	9	70 0.6×	46 0.5×	128 2.5×	81 1.8×	25 0.6×	13	286
Efrat Luttwak Israel	10	39 0.3×	183 1.8×	54 1.1×	19 0.4×	34 0.8×	29	330
Takahisa� Nakanishi Japan	11	125 1.1×	84 0.8×	125 2.5×	59 1.3×	55 1.3×	38	381
DJ Inwards United States	8	238 2.1×	110 1.1×	54 1.1×	36 0.8×	54 1.2×	9	298
Diego Carbonell Spain	11	116 1.0×	56 0.5×	61 1.2×	20 0.4×	41 0.9×	31	258
Hiroyuki Ohigashi Japan	9	136 1.2×	75 0.7×	103 2.0×	16 0.3×	82 1.9×	48	310
Diahann T. S. L. Jansen Netherlands	13	53 0.5×	35 0.3×	190 3.7×	70 1.5×	50 1.1×	20	401
Ana Pérez‐Corral Spain	8	196 1.7×	64 0.6×	84 1.6×	13 0.3×	54 1.2×	31	275

Countries citing papers authored by Tomoyasu Jo

Since Specialization

Citations

This map shows the geographic impact of Tomoyasu Jo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyasu Jo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyasu Jo more than expected).

Fields of papers citing papers by Tomoyasu Jo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyasu Jo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyasu Jo. The network helps show where Tomoyasu Jo may publish in the future.

Co-authorship network of co-authors of Tomoyasu Jo

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyasu Jo. A scholar is included among the top collaborators of Tomoyasu Jo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyasu Jo. Tomoyasu Jo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jo, Tomoyasu, Yasuyuki Arai, Toshio Heike, et al.. (2025). Severe cases of local cytokine release syndrome (CRS); craniocervical edema soon after chimeric antigen T-cell (CAR-T) therapy. Oxford Medical Case Reports. 2025(1). omae164–omae164. 1 indexed citations

Jo, Tomoyasu, Toshio Heike, Junya Kanda, et al.. (2025). Prolonged chimeric antigen receptor‐T apheresis to infusion time is associated with inferior outcomes in diffuse large B‐cell lymphoma. British Journal of Haematology. 207(4). 1484–1494. 1 indexed citations

Kambe, Naotomo, Norimitsu Inoue, Yadong Zhou, et al.. (2025). Neutrophils predominate as IL1B-expressing cells in Schnitzler syndrome: Insights from the SCan study to evaluate the efficacy and safety of canakinumab in Japanese patients. Allergology International. 74(4). 605–615.

Jo, Tomoyasu, Yasuyuki Arai, Tadafumi Shimizu, et al.. (2025). Consistent ex vivo cell proliferation during manufacturing predicts favourable outcomes post‐CAR‐T‐cell therapy. British Journal of Haematology. 207(3). 1002–1010.

Jo, Tomoyasu, Yu Akahoshi, Tadakazu Kondo, et al.. (2024). First complete remission favours haploidentical haematopoietic stem cell transplantation with post‐transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia. British Journal of Haematology. 204(5). 1913–1919. 2 indexed citations

Jo, Tomoyasu, Yasuyuki Arai, Toshio Heike, et al.. (2024). Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy. Clinical and Experimental Medicine. 24(1). 105–105. 2 indexed citations

Arai, Yasuyuki, Toshio Heike, Tomoyasu Jo, et al.. (2024). Fluctuation of physical function during chimeric antigen receptor T‐cell therapy during rehabilitation intervention: Real‐world data and risk factor analyses. SHILAP Revista de lepidopterología. 5(6). 1252–1259. 2 indexed citations

Jo, Tomoyasu, Yasuyuki Arai, Toshio Heike, et al.. (2024). Clinical Impact of Cytokine Release Syndrome on Prolonged Hematotoxicity after Chimeric Antigen Receptor T Cell Therapy: KyoTox A-Score, a Novel Prediction Model. Transplantation and Cellular Therapy. 30(4). 404–414. 8 indexed citations

Kambe, Naotomo, Mayuko Yamamoto, K. Takemura, et al.. (2024). Investigator-initiated, multi-center, single-arm, open-label study of the effectiveness of canakinumab in Japanese patients with Schnitzler syndrome. Allergology International. 74(2). 254–262. 3 indexed citations

10.

Jo, Tomoyasu, Yasuyuki Arai, Tadakazu Kondo, et al.. (2023). Prognostic impact of complex and/or monosomal karyotypes in post‐transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach. British Journal of Haematology. 202(2). 356–368. 1 indexed citations

11.

Arai, Yasuyuki, Tomoyasu Jo, Chisaki Mizumoto, et al.. (2023). Impact of Antimicrobial Drug-Drug Interactions on Acute Kidney Injury after Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 29(10). 634.e1–634.e7. 3 indexed citations

12.

Jo, Tomoyasu, Yasuyuki Arai, Junya Kanda, et al.. (2023). A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. SHILAP Revista de lepidopterología. 3(1). 67–67. 7 indexed citations

13.

Morita, Makiko, Yasuyuki Arai, Takashi Ishihara, et al.. (2022). Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma. Blood Advances. 6(14). 4216–4223. 8 indexed citations

14.

Jo, Tomoyasu, Yasuyuki Arai, Kazuo Hatanaka, et al.. (2022). Adverse effect of donor-specific anti-human leukocyte antigen (HLA) antibodies directed at HLA-DP/-DQ on engraftment in cord blood transplantation. Cytotherapy. 25(4). 407–414. 4 indexed citations

15.

Ishii, Akira, Tomoyasu Jo, Yasuyuki Arai, et al.. (2021). Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor era. Cytotherapy. 24(1). 49–58. 7 indexed citations

16.

Jo, Tomoyasu, Satoru Yoshihara, Yasuyuki Arai, et al.. (2021). [Clinical experience of leukapheresis for CD19 CAR-T cell therapy].. PubMed. 62(3). 163–169. 2 indexed citations

17.

Jo, Tomoyasu, Kazuya Okada, Yasuyuki Arai, et al.. (2019). Curative potential of fludarabine, melphalan, and non-myeloablative dosage of busulfan in elderly patients with myeloid malignancy. International Journal of Hematology. 111(2). 247–255. 1 indexed citations

18.

Arai, Yasuyuki, et al.. (2017). Comparison of up-front treatments for newly diagnosed immune thrombocytopenia -a systematic review and network meta-analysis. Haematologica. 103(1). 163–171. 15 indexed citations

19.

Jo, Tomoyasu, et al.. (2013). 27 Cases of Paraneoplastic Autoimmune Thrombocytopenia in Solid Tumors. Annals of Oncology. 24. ix81–ix81.

20.

Morioka, Daisuke, Hiroto Egawa, Mureo Kasahara, et al.. (2006). Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transplantation. 13(1). 80–90. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact